Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration

This study explored the expression of several miRNAs reported to be deregulated in age-related macular degeneration (AMD). Total RNA was isolated from sera from patients with dry AMD (<i>n</i> = 12), wet AMD (<i>n</i> = 14), and controls (<i>n</i> = 10). Forty-two...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanan ElShelmani, Ian Brennan, David J. Kelly, David Keegan
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/a434f79be21b4310bcd04da32ae1e39a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a434f79be21b4310bcd04da32ae1e39a
record_format dspace
spelling oai:doaj.org-article:a434f79be21b4310bcd04da32ae1e39a2021-11-25T17:55:23ZDifferential Circulating MicroRNA Expression in Age-Related Macular Degeneration10.3390/ijms2222123211422-00671661-6596https://doaj.org/article/a434f79be21b4310bcd04da32ae1e39a2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12321https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067This study explored the expression of several miRNAs reported to be deregulated in age-related macular degeneration (AMD). Total RNA was isolated from sera from patients with dry AMD (<i>n</i> = 12), wet AMD (<i>n</i> = 14), and controls (<i>n</i> = 10). Forty-two previously investigated miRNAs were selected based on published data and their role in AMD pathogenesis, such as angiogenic and inflammatory effects, and were co-analysed using a miRCURY LNA miRNA SYBR<sup>®</sup> Green PCR kit via quantitative real-time polymerase chain reaction (qRT-PCR) to validate their presence. Unsupervised hierarchical clustering indicated that AMD serum specimens have a different miRNA profile to healthy controls. We successfully validated the differentially regulated miRNAs in serum from AMD patients versus controls. Eight miRNAs (hsa-let-7a-5p, hsa-let-7d-5p, hsa-miR-23a-3p, hsa-miR-301a-3p, hsa-miR-361-5p, hsa-miR-27b-3p, hsa-miR-874-3p, hsa-miR-19b-1-5p) showed higher expression in the serum of dry AMD patients than wet AMD patients and compared with healthy controls. Increased quantities of certain miRNAs in the serum of AMD patients indicate that these miRNAs could potentially serve as diagnostic AMD biomarkers and might be used as future AMD treatment targets. The discovery of significant serum miRNA biomarkers in AMD patients would provide an easy screening tool for at-risk populations.Hanan ElShelmaniIan BrennanDavid J. KellyDavid KeeganMDPI AGarticlemicroRNAage-related macular degenerationbiomarkersserumdry AMDwet AMDBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12321, p 12321 (2021)
institution DOAJ
collection DOAJ
language EN
topic microRNA
age-related macular degeneration
biomarkers
serum
dry AMD
wet AMD
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle microRNA
age-related macular degeneration
biomarkers
serum
dry AMD
wet AMD
Biology (General)
QH301-705.5
Chemistry
QD1-999
Hanan ElShelmani
Ian Brennan
David J. Kelly
David Keegan
Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
description This study explored the expression of several miRNAs reported to be deregulated in age-related macular degeneration (AMD). Total RNA was isolated from sera from patients with dry AMD (<i>n</i> = 12), wet AMD (<i>n</i> = 14), and controls (<i>n</i> = 10). Forty-two previously investigated miRNAs were selected based on published data and their role in AMD pathogenesis, such as angiogenic and inflammatory effects, and were co-analysed using a miRCURY LNA miRNA SYBR<sup>®</sup> Green PCR kit via quantitative real-time polymerase chain reaction (qRT-PCR) to validate their presence. Unsupervised hierarchical clustering indicated that AMD serum specimens have a different miRNA profile to healthy controls. We successfully validated the differentially regulated miRNAs in serum from AMD patients versus controls. Eight miRNAs (hsa-let-7a-5p, hsa-let-7d-5p, hsa-miR-23a-3p, hsa-miR-301a-3p, hsa-miR-361-5p, hsa-miR-27b-3p, hsa-miR-874-3p, hsa-miR-19b-1-5p) showed higher expression in the serum of dry AMD patients than wet AMD patients and compared with healthy controls. Increased quantities of certain miRNAs in the serum of AMD patients indicate that these miRNAs could potentially serve as diagnostic AMD biomarkers and might be used as future AMD treatment targets. The discovery of significant serum miRNA biomarkers in AMD patients would provide an easy screening tool for at-risk populations.
format article
author Hanan ElShelmani
Ian Brennan
David J. Kelly
David Keegan
author_facet Hanan ElShelmani
Ian Brennan
David J. Kelly
David Keegan
author_sort Hanan ElShelmani
title Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
title_short Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
title_full Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
title_fullStr Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
title_full_unstemmed Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
title_sort differential circulating microrna expression in age-related macular degeneration
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/a434f79be21b4310bcd04da32ae1e39a
work_keys_str_mv AT hananelshelmani differentialcirculatingmicrornaexpressioninagerelatedmaculardegeneration
AT ianbrennan differentialcirculatingmicrornaexpressioninagerelatedmaculardegeneration
AT davidjkelly differentialcirculatingmicrornaexpressioninagerelatedmaculardegeneration
AT davidkeegan differentialcirculatingmicrornaexpressioninagerelatedmaculardegeneration
_version_ 1718411877399134208